Cardiac Implantable Electronic Device Market

Cardiac Implantable Electronic Device Market (Product: Pacemakers, Implantable Cardioverter Defibrillators, and Implantable Cardiac Loop Recorders) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cardiac Implantable Electronic Device Market Outlook 2031

  • The global industry was valued at US$ 10.8 Bn in 2021
  • It is projected to grow at a CAGR of 3.6% from 2022 to 2031 and reach more than US$ 16.1 Bn by the end of 2031

Analysts’ Viewpoint

Cardiac implantable electronic devices (CIEDs) are an integral part of cardiology in general and electrophysiology in particular. Cardiovascular implantable electronic devices have become established treatments for various cardiac arrhythmias. Large geriatric population with cardiac diseases is driving the demand for CIEDs. Advancement in lead and device technology, simplification of the implant technique, and rise in demand for cardiac implanted electronic devices for continuous heart monitoring and to support heart functionality are the major factors propelling the global cardiac implantable electronic devices market size.

Companies are striving to introduce new products to meet the growing demand for implantable devices. The size of these devices has been reduced significantly in the past few years in order to promote minimally invasive surgery that is less risky and a convenient option for patients.

Cardiac Implantable Electronic Device Market

Cardiac Implantable Electronic Device Market Introduction

CIEDs are sophisticated modern devices that provide patients with several beneficial effects such as increased survival and enhanced quality of life. Cardiovascular implantable electronic devices include pacemakers, implantable cardioverter defibrillators (ICDs), and loop recorders. Pacemaker is a small device placed in abdomen or chest. It is used in case of slower heart rate than normal. Implantable cardioverter defibrillators (ICDs) are used if the heart beats way too faster than normal. Loop recorder records the rhythm of the heart.

Request a sample to get extensive insights into the Cardiac Implantable Electronic Device Market

Need for Early Detection of Heart Conditions Driving Market Progress

Ambulatory cardiac monitoring devices assist in continuous monitoring of the heart, allowing the detection of chronic heart conditions such as stroke and heart failure. Focus on functional and structural abnormalities of the arteries and heart makes it possible to identify and track disease progression.

According to the American Heart Association's 2017 Heart Diseases and Stroke Statistics update, the number of people diagnosed with heart failure is rising and will increase by 46% by 2030, resulting in more than 8 million people suffering from heart failure. Globally, 22 million people suffer from congestive heart failure, with an additional 2 million diagnosed each year. Thus, rise in number of cardiac patients who suffer from chronic heart diseases is expected to fuel market expansion.

Acceptance of Subcutaneous Cardiac Monitor Devices Fueling Global CIEDS Industry

Technological advancements have paved the way for innovative subcutaneous version of cardiac monitoring devices for better alertness of cardiac patients, which helps them prevent cardiac stroke and other complicated conditions. Usage of implantable cardiac monitors (ICMs), also known as implantable electronic loop recorders (ILRs), has increased. These devices keep track of the irregularity of heart rhythm. ICMs are small subcutaneous devices that monitor the heart rhythm and record events for a number of years.

Insertable cardiac monitors are primarily used to monitor patients with syncope or stroke of unknown origin, and infrequent rhythm abnormalities. They are also used for long-term monitoring of atrial fibrillation post ablation. Insertable cardiac monitors (ICMs) are small, subcutaneously implanted devices offering continuous ambulatory electrocardiogram (ECG) monitoring with a lifespan of up to three years. Increase in demand for implantable cardiac electronic devices is accelerating industry expansion due to the continuous monitoring of irregular cardiac rhythms.

Request a custom report on Cardiac Implantable Electronic Device Market

Rise in Continuous Monitoring of Arrhythmias Propelling Implantable Loop Recorders Segment

In terms of product, the global cardiac implantable electronic device market has been classified into pacemakers, implantable cardioverter defibrillators, and implantable cardiac loop recorders. The implantable cardioverter defibrillators segment dominated the global business in 2021 owing to large number of users. However, the implantable loop recorders segment is likely to grow at a faster pace during the forecast period.

Continuous monitoring of health status of a heart patient is crucial. Development and usage of wireless communication technologies, wearable detecting devices, and small energy consumption microchips with high efficiency data handling algorithms have made continuous monitoring possible with implantable loop recorder devices. Thus, rise in demand for continuous monitoring of heart activities is driving the implantable loop recorders segment.

Availability of Wide Range of Products and Treatments Bolstering Hospitals Segment

Based on end-user, the hospitals segment accounted for more than 60.0% share of the global cardiac implantable electronic device market in 2021. The segment is anticipated to grow rapidly in the near future in Asia Pacific and the Middle East due to availability of a range of products and treatments under one roof. The segment is likely to lose market share in North America owing to the rise in preference for ambulatory centers in the region.

Regional Outlook of Global Cardiac Implantable Electronic Device Market

North America held significant share of the industry in 2021 due to rise in awareness about CIEDs and availability of advanced products in the region.

Increase in chronic diseases among the geriatric population, growth in awareness about the benefits of CIEDs in countries such as India and Indonesia, and surge in government investments in healthcare systems in countries in South Asia are anticipated to augment the business in Asia Pacific in the next few years.

Analysis of Key Players

The global cardiac implantable electronic device market is consolidated, with the presence of small number of players. Key players operating in the industry are Abbott, Medtronic plc, Boston Scientific Corporation, Biotronic AG, Angel Medical Systems, Inc., MicroPort, Cook Medical, Inc., Lepu Medical Technology(Beijing) Co., Ltd., Vitatron, and MEDICO S.R.L.

Leading players have adopted strategies such as new product development, product approvals, product launches, partnerships, and mergers.

Key Developments in Global Cardiac Implantable Electronic Device Market

  • In July 2021, Medtronic plc, the world's leading medical technology company, announced the U.S. FDA approval for two AccuRhythm AI algorithms for usage with the LINQ II insertable cardiac monitor (ICM). AccuRhythm AI applies artificial intelligence (AI) to LINQ II heart rhythm event data, improving the accuracy of information physicians receive and allowing them to better diagnose and treat abnormal heart rhythms.
  • In July 2021, Abbott Laboratories announced the launch of its latest implantable cardiac monitor (ICM), the Jot Dx, in the U.S. Jot Dx ICM can be used to view abnormal cardiac rhythm data or to inform via a unique feature that simplifies recorded arrhythmia rhythms. This technology allows for remote detection of cardiac arrhythmias in patients as well as improved diagnostic accuracy. SyncUP, a personalized service that provides customized education and training to help patients connect to and stay connected to the ICM, is used by Jot Dx ICM.

These players have been profiled in the cardiac implantable electronic device market report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Global Cardiac Implantable Electronic Device Market Snapshot

Attribute

Detail

Size in 2021

US$ 10.8 Bn

Forecast (Value) in 2031

More than US$ 16.1 Bn

Growth Rate (CAGR)

3.6%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, etc.

Competition Landscape

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • Pacemakers
      • Single-chamber
      • Dual-chamber
      • Biventricular
    • Implantable Cardioverter Defibrillators
      • Transvenous ICD
      • Subcutaneous ICD
    • Implantable Cardiac Loop Recorders
  • Application
    • Arrhythmia
    • Heart Rhythm Monitoring
    • Heart Block/Failure
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Abbott
  • Medtronic plc
  • Boston Scientific Corporation
  • Biotronic AG
  • Angel Medical Systems, Inc.
  • MicroPort
  • Cook Medical, Inc.
  • Lepu Medical Technology(Beijing) Co., Ltd.
  • Vitatron
  • MEDICO S.R.L.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global cardiac implantable electronic device market in 2021?

The industry was valued at US$ 10.8 Bn in 2021.

How big will it be in 2031?

It is projected to reach more than US$ 16.1 Bn by 2031.

What will be the CAGR during the forecast period?

The CAGR is anticipated be 3.6% from 2022 to 2031.

What are the prominent trends that affect market growth?

Rise in cardiac disease prevalence among aging population and increase in launch of innovative products.

What was the market share of the leading segment?

The implantable cardioverter defibrillators segment held more than 50.0% share in 2021.

Which region will account for major share during the forecast period?

North America is expected to account for major share from 2022 to 2031.

Who are the prominent players in the global market?

Abbott, Medtronic plc, Boston Scientific Corporation, Biotronic AG, Angel Medical Systems, Inc., MicroPort, Cook Medical, Inc., Lepu Medical Technology (Beijing) Co., Ltd., Vitatron, and MEDICO S.R.L.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cardiac Implantable Electronic Device Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Overview

        4.2. Market Dynamics

            4.2.1. Drivers

            4.2.2. Restraints

            4.2.3. Opportunities

        4.3. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, 2017–2031

            4.3.1. Global Cardiac Implantable Electronic Device Market Revenue Projection (US$ Mn)

    5. Market Outlook

        5.1. Technological Advancement

        5.2. Cardiovascular Disease Prevalence

        5.3. Value Chain Analysis

        5.4. COVID-19 Impact Analysis

    6. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Product

        6.1. Key Findings/Developments

        6.2. Introduction & Definition

        6.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            6.3.1. Pacemakers

                6.3.1.1. Single-chamber

                6.3.1.2. Dual-chamber

                6.3.1.3. Biventricular

            6.3.2. Implantable Cardioverter Defibrillator

                6.3.2.1. Transvenous ICD

                6.3.2.2. Subcutaneous ICD

            6.3.3. Implantable Cardiac Loop Recorders

        6.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product

    7. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Application

        7.1. Key Findings/Developments

        7.2. Introduction & Definition

        7.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            7.3.1. Arrhythmia

            7.3.2. Heart Rhythm Monitoring

            7.3.3. Heart Block/Failure

            7.3.4. Others

        7.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application

    8. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by End-user

        8.1. Key Findings/Developments

        8.2. Introduction & Definition

        8.3. Global Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgical Centers

            8.3.3. Others

        8.4. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user

    9. Global Cardiac Implantable Electronic Device Market Analysis and Forecast, by Region

        9.1. Geographical Representation

        9.2. Global Cardiac Implantable Electronic Device Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Region

    10. North America Cardiac Implantable Electronic Device Market Analysis and Forecast

        10.1. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Country, 2017–2031

        10.2. North America Cardiac Implantable Electronic Device Market Value Forecast, by Country, 2017–2031

            10.2.1. U.S.

            10.2.2. Canada

        10.3. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031

        10.4. North America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            10.4.1. Pacemakers

                10.4.1.1. Single-chamber

                10.4.1.2. Dual-chamber

                10.4.1.3. Biventricular

            10.4.2. Implantable Cardioverter Defibrillators

                10.4.2.1. Transvenous ICD

                10.4.2.2. Subcutaneous ICD

            10.4.3. Implantable Cardiac Loop Recorders

        10.5. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031

        10.6. North America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            10.6.1. Arrhythmia

            10.6.2. Heart Rhythm Monitoring

            10.6.3. Heart Block/Failure

            10.6.4. Others

        10.7. North America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031

        10.8. North America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            10.8.1. Hospitals

            10.8.2. Ambulatory Surgical Centers

            10.8.3. Others

        10.9. North America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)

            10.9.1. By Country

            10.9.2. By Product

            10.9.3. By Application

            10.9.4. By End-user

    11. Europe Cardiac Implantable Electronic Device Market Analysis and Forecast

        11.1. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031

            11.1.1. Germany

            11.1.2. France

            11.1.3. U.K.

            11.1.4. Spain

            11.1.5. Italy

            11.1.6. Rest of Europe

        11.2. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031

        11.3. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            11.3.1. Pacemakers

                11.3.1.1. Single-chamber

                11.3.1.2. Dual-chamber

                11.3.1.3. Biventricular

            11.3.2. Implantable Cardioverter Defibrillators

                11.3.2.1. Transvenous ICD

                11.3.2.2. Subcutaneous ICD

            11.3.3. Implantable Cardiac Loop Recorders

        11.4. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031

        11.5. Europe Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            11.5.1. Arrhythmia

            11.5.2. Heart Rhythm Monitoring

            11.5.3. Heart Block/Failure

            11.5.4. Others

        11.6. Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031

        11.7. Europe Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            11.7.1. Hospitals

            11.7.2. Ambulatory Surgical Centers

            11.7.3. Others

        11.8. Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)

            11.8.1. By Country/Sub-region

            11.8.2. By Product

            11.8.3. By Application

            11.8.4. By End-user

    12. Asia Pacific Cardiac Implantable Electronic Device Market Analysis and Forecast

        12.1. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031

            12.1.1. China

            12.1.2. Japan

            12.1.3. India

            12.1.4. Australia & New Zealand

            12.1.5. Rest of Asia Pacific

        12.2. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031

        12.3. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            12.3.1. Pacemakers

                12.3.1.1. Single-chamber

                12.3.1.2. Dual-chamber

                12.3.1.3. Biventricular

            12.3.2. Implantable Cardioverter Defibrillators

                12.3.2.1. Transvenous ICD

                12.3.2.2. Subcutaneous ICD

            12.3.3. Implantable Cardiac Loop Recorders

        12.4. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031

        12.5. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            12.5.1. Arrhythmia

            12.5.2. Heart Rhythm Monitoring

            12.5.3. Heart Block/Failure

            12.5.4. Others

        12.6. Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031

        12.7. Asia Pacific Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            12.7.1. Hospitals

            12.7.2. Ambulatory Surgical Centers

            12.7.3. Others

        12.8. Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)

            12.8.1. By Country/Sub-region

            12.8.2. By Product

            12.8.3. By Application

            12.8.4. By End-user

    13. Latin America Cardiac Implantable Electronic Device Market Analysis and Forecast

        13.1. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017-2027

            13.1.1. Brazil

            13.1.2. Mexico

            13.1.3. Rest of Latin America

        13.2. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031

        13.3. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            13.3.1. Pacemakers

                13.3.1.1. Single-chamber

                13.3.1.2. Dual-chamber

                13.3.1.3. Biventricular

            13.3.2. Implantable Cardioverter Defibrillators

                13.3.2.1. Transvenous ICD

                13.3.2.2. Subcutaneous ICD

            13.3.3. Implantable Cardiac Loop Recorders

        13.4. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031

        13.5. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            13.5.1. Arrhythmia

            13.5.2. Heart Rhythm Monitoring

            13.5.3. Heart Block/Failure

            13.5.4. Others

        13.6. Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031

        13.7. Latin America Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            13.7.1. Hospitals

            13.7.2. Ambulatory Surgical Centers

            13.7.3. Others

        13.8. Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)

            13.8.1. By Country/Sub-region

            13.8.2. By Product

            13.8.3. By Application

            13.8.4. By End-user

    14. Middle East & Africa Cardiac Implantable Electronic Device Market Analysis and Forecast

        14.1. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Country/Sub-region, 2017–2031

            14.1.1. GCC Countries

            14.1.2. South Africa

            14.1.3. Rest of Middle East & Africa

        14.2. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021–2031

        14.3. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Product, 2017–2031

            14.3.1. Pacemakers

                14.3.1.1. Single-chamber

                14.3.1.2. Dual-chamber

                14.3.1.3. Biventricular

            14.3.2. Implantable Cardioverter Defibrillators

                14.3.2.1. Transvenous ICD

                14.3.2.2. Subcutaneous ICD

            14.3.3. Implantable Cardiac Loop Recorders

        14.4. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021–2031

        14.5. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by Application, 2017–2031

            14.5.1. Arrhythmia

            14.5.2. Heart Rhythm Monitoring

            14.5.3. Heart Block/Failure

            14.5.4. Others

        14.6. Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021–2031

        14.7. Middle East & Africa Cardiac Implantable Electronic Device Market Value Forecast, by End-user, 2017–2031

            14.7.1. Hospitals

            14.7.2. Ambulatory Surgical Centers

            14.7.3. Others

        14.8. Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis (2022–2031)

            14.8.1. By Country/Sub-region

            14.8.2. By Product

            14.8.3. By Application

            14.8.4. By End-user

    15. Competition Landscape

        15.1. Competition Matrix

        15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

            15.2.1. Medtronic plc (HQ, Business Segments, Employee Strength)

                15.2.1.1. Company Details

                15.2.1.2. Company Description

                15.2.1.3. Business Overview

                15.2.1.4. SWOT Analysis

                15.2.1.5. Financial Analysis

                15.2.1.6. Strategic Overview

            15.2.2. Biotronic AG (HQ, Business Segments, Employee Strength)

                15.2.2.1. Company Details

                15.2.2.2. Company Description

                15.2.2.3. Business Overview

                15.2.2.4. SWOT Analysis

                15.2.2.5. Strategic Overview

            15.2.3. Abbott Laboratories (HQ, Business Segments, Employee Strength)

                15.2.3.1. Company Details

                15.2.3.2. Company Description

                15.2.3.3. Business Overview

                15.2.3.4. SWOT Analysis

                15.2.3.5. Strategic Overview

            15.2.4. Angel Medical Systems, Inc. (HQ, Business Segments, Employee Strength)

                15.2.4.1. Company Details

                15.2.4.2. Company Description

                15.2.4.3. Business Overview

                15.2.4.4. SWOT Analysis

                15.2.4.5. Strategic Overview

            15.2.5. Boston Scientific Corporation (HQ, Business Segments, Employee Strength)

                15.2.5.1. Company Details

                15.2.5.2. Company Description

                15.2.5.3. Business Overview

                15.2.5.4. SWOT Analysis

                15.2.5.5. Financial Analysis

                15.2.5.6. Strategic Overview

            15.2.6. MicroPort (HQ, Business Segments, Employee Strength)

                15.2.6.1. Company Details

                15.2.6.2. Company Description

                15.2.6.3. Business Overview

                15.2.6.4. SWOT Analysis

                15.2.6.5. Financial Analysis

                15.2.6.6. Strategic Overview

            15.2.7. Lepu Medical Technology (Beijing) Co., Ltd. (HQ, Business Segments, Employee Strength)

                15.2.7.1. Company Details

                15.2.7.2. Company Description

                15.2.7.3. Business Overview

                15.2.7.4. SWOT Analysis

                15.2.7.5. Financial Analysis

                15.2.7.6. Strategic Overview

            15.2.8. MEDICO S.R.L. (HQ, Business Segments, Employee Strength)

                15.2.8.1. Company Details

                15.2.8.2. Company Description

                15.2.8.3. Business Overview

                15.2.8.4. SWOT Analysis

                15.2.8.5. Financial Analysis

                15.2.8.6. Strategic Overview

            15.2.9. Vitatron (HQ, Business Segments, Employee Strength)

                15.2.9.1. Company Details

                15.2.9.2. Company Description

                15.2.9.3. Business Overview

                15.2.9.4. SWOT Analysis

                15.2.9.5. Financial Analysis

                15.2.9.6. Strategic Overview

            15.2.10. Cook Medical Inc. (HQ, Business Segments, Employee Strength)

                15.2.10.1. Company Details

                15.2.10.2. Company Description

                15.2.10.3. Business Overview

                15.2.10.4. SWOT Analysis

                15.2.10.5. Financial Analysis

                15.2.10.6. Strategic Overview

    List of Tables

    Table 01: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers 2017–2031

    Table 03: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031

    Table 04: Global Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 05: Global Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 06: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 07: North America Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

    Table 08: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 09: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031

    Table 10: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031

    Table 11: North America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: North America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Europe Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 15: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031

    Table 16: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031

    Table 17: Europe Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 18: Europe Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 19: Asia Pacific Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 20: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 21: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031

    Table 22: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031

    Table 23: Asia Pacific Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Asia Pacific Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 25: Latin America Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 27: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031

    Table 28: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Implantable Cardioverter Defibrillators, 2017–2031

    Table 29: Latin America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 30: Latin America Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 31: Middle East & Africa Cardiac Implantable Electronic Device Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 32: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Product, 2017–2031

    Table 33: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, by Pacemakers, 2017–2031

    Table 34: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, Implantable Cardioverter Defibrillators, 2017–2031

    Table 35: Middle East & Africa Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 36: Middle East & Africa Cardiac Implantable Electronic Device Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Cardiac Implantable Electronic Device Market Value Share, by Region, 2021

    Figure 03: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Product, 2021 and 2031

    Figure 04: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product 2022–2031

    Figure 05: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Pacemakers, 2017–2031

    Figure 06: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Implantable Cardioverter Defibrillators, 2017–2031

    Figure 07: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Implantable Cardiac Loop Recorders, 2017–2031

    Figure 08: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 09: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 10: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Arrhythmia, 2017–2031

    Figure 11: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Heart Rhythm Monitoring, 2017–2031

    Figure 12: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Heart Block/Failure, 2017–2031

    Figure 13: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 14: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 15: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 16: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Hospitals, 2017–2031

    Figure 17: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

    Figure 18: Global Cardiac Implantable Electronic Device Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 19: Global Cardiac Implantable Electronic Device Market Value Share Analysis, by Region, 2021 and 2031

    Figure 20: Global Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Region, 2022–2031

    Figure 21: North America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 22: North America Cardiac Implantable Electronic Device Market Value Share (%), by Country, 2021 and 2031

    Figure 23: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country, 2022–2031

    Figure 24: North America Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031

    Figure 25: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031

    Figure 26: North America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 27: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 28: North America Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031

    Figure 29: North America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 30: Europe Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 31: Europe Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 32: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 33: Europe Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031

    Figure 34: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031

    Figure 35: Europe Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 36: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 37: Europe Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031

    Figure 38: Europe Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 39: Asia Pacific Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 40: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 41: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 42: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031

    Figure 43: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031

    Figure 44: Asia Pacific Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 45: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 46: Asia Pacific Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031

    Figure 47: Asia Pacific Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 48: Latin America Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 49: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 50: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 51: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031

    Figure 52: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031

    Figure 53: Latin America Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 54: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 55: Latin America Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031

    Figure 56: Latin America Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 57: Middle East & Africa Cardiac Implantable Electronic Device Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 58: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 59: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 60: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by Product, 2021 and 2031

    Figure 61: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Product, 2022–2031

    Figure 62: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share Analysis, by Application, 2021 and 2031

    Figure 63: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by Application, 2022–2031

    Figure 64: Middle East & Africa Cardiac Implantable Electronic Device Market Value Share (%), by End-user, 2021 and 2031

    Figure 65: Middle East & Africa Cardiac Implantable Electronic Device Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved